Avemom-F

Avemom-F is a topical combination cream developed by Avancer Labs, containing the corticosteroid mometasone furoate (0.1% w/w) and the antibiotic fusidic acid (2% w/w). It is indicated for the treatment of inflammatory skin conditions, such as eczema, psoriasis, and various forms of dermatitis, where secondary bacterial infection is present or likely to occur. Mometasone furoate acts as a medium-potency corticosteroid to reduce inflammation, redness, and itching, while fusidic acid acts as a narrow-spectrum antibiotic that inhibits bacterial protein synthesis, targeting common pathogens like *Staphylococcus aureus*.

Brand names

Avemom FAvemom-F

Other names

fusidic acid + mometasonefusidic acid + mometasone furoate